ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 567,39
-0,86%
Dow Jones
40 211,72
0,00%
DAX
18 479,96
-0,65%
Brent Oil
82,995
-1,59%
Bitcoin
63 730,06
-1,73%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NYSE
  6. Teva Pharmaceutical Industries Ltd (TEVA)

  7. Teva Pharmaceutical Industries Ltd (TEVA) Actualités

TEVA

Teva Pharmaceutical Indu... (TEVA)

Teva Pharmaceutical Industries Ltd
De:
Trier par:
 Showing the most relevant articles for your search:NYSE:TEVA
DateHeureSourceTitreSymboleSociété
12/11/201500h28The Motley FoolWhy Insys Therapeutics Shares Dropped TodayNYSE:TEVATeva Pharmaceutical Industries Ltd
09/11/201514h58Edgar (US Regulatory)Report of Foreign Issuer (6-k)NYSE:TEVATeva Pharmaceutical Industries Ltd
09/11/201514h00Business WireTeva Announces Breakthrough Therapy Designation for SD-809 Granted by FDA for the Treatment of Tardive DyskinesiaNYSE:TEVATeva Pharmaceutical Industries Ltd
04/11/201515h20Dow Jones NewsAllergan Sales Soar, Topping ExpectationsNYSE:TEVATeva Pharmaceutical Industries Ltd
04/11/201514h00Business WireTeva to Present New Respiratory Data at the 2015 Annual Scientific Meeting of the American College of Allergy, Asthma & Immun...NYSE:TEVATeva Pharmaceutical Industries Ltd
31/10/201521h41The Motley FoolTeva Pharmaceutical Industries Ltd. Sees Stronger 2015 After Q3 ResultsNYSE:TEVATeva Pharmaceutical Industries Ltd
31/10/201514h21The Motley FoolGeneric Copaxone Isn't Derailing Teva Pharmaceuticals...YetNYSE:TEVATeva Pharmaceutical Industries Ltd
29/10/201515h20Dow Jones NewsAllergan Confirms Pfizer TalksNYSE:TEVATeva Pharmaceutical Industries Ltd
29/10/201514h10Dow Jones NewsTeva Boosts Outlook as Results Top EstimatesNYSE:TEVATeva Pharmaceutical Industries Ltd
29/10/201512h00Business WireTeva Reports Third Quarter 2015 ResultsNYSE:TEVATeva Pharmaceutical Industries Ltd
24/10/201515h12The Motley FoolSpecialty Drug Classes That Are Costing Consumers an Arm and a LegNYSE:TEVATeva Pharmaceutical Industries Ltd
23/10/201519h39PR Newswire (US)New Data Presented at European Society of Gynecology Congress Show Most Women Would Prefer to Have Less Frequent PeriodsNYSE:TEVATeva Pharmaceutical Industries Ltd
23/10/201503h45The Motley FoolBiogen's Beat, Raise, and YawnNYSE:TEVATeva Pharmaceutical Industries Ltd
15/10/201515h24Business WireTeva to Host Third Quarter 2015 Financial Results Conference Call and Webcast on October 29, 2015NYSE:TEVATeva Pharmaceutical Industries Ltd
12/10/201514h30Business WireTeva Announces Exclusive Launch of Generic Avodart® Capsules in the United StatesNYSE:TEVATeva Pharmaceutical Industries Ltd
08/10/201514h00Business WireTeva Announces Approval of Three-Times-A-Week COPAXONE® 40 mg/mL in Russia for the Treatment of Relapsing-Remitting Multiple...NYSE:TEVATeva Pharmaceutical Industries Ltd
07/10/201502h58Dow Jones NewsCorrection to Alkermes Story From Oct. 5NYSE:TEVATeva Pharmaceutical Industries Ltd
06/10/201514h00Business WireTeva Reinforces Focus on Advancing Multiple Sclerosis Treatment at 31st ECTRIMS CongressNYSE:TEVATeva Pharmaceutical Industries Ltd
06/10/201503h06Dow Jones NewsFDA Approves Alkermes' Schizophrenia Treatment AristadaNYSE:TEVATeva Pharmaceutical Industries Ltd
01/10/201515h50Dow Jones NewsTeva to Acquire Mexico Drug Maker Rimsa for $2.3 BillionNYSE:TEVATeva Pharmaceutical Industries Ltd
01/10/201515h44Dow Jones NewsU.S. Hot Stocks: Hot Stocks to WatchNYSE:TEVATeva Pharmaceutical Industries Ltd
01/10/201515h18Dow Jones NewsTeva to Acquire Mexico's Rimsa for $2.3 BillionNYSE:TEVATeva Pharmaceutical Industries Ltd
01/10/201514h00Business WireTeva Accelerates its Emerging Markets Growth Strategy with the Acquisition of Rimsa, a Leading Independent Pharmaceutical Com...NYSE:TEVATeva Pharmaceutical Industries Ltd
30/09/201514h00Business WireImportant New Data from Teva's TEV-48125 Phase 2B Migraine Program Published in Lancet Neurology in Back-to-Back ArticlesNYSE:TEVATeva Pharmaceutical Industries Ltd
29/09/201500h10Dow Jones NewsAllergan Sees 10% Rise in Branded RevenueNYSE:TEVATeva Pharmaceutical Industries Ltd
28/09/201509h00Business WireTeva Announces Approval of COPAXONE® in Japan for the Prevention of Relapse of Multiple SclerosisNYSE:TEVATeva Pharmaceutical Industries Ltd
27/09/201511h00Business WireTeva Presents New Reslizumab Data at European Respiratory Society (ERS) International Congress 2015NYSE:TEVATeva Pharmaceutical Industries Ltd
25/09/201515h00Business WireTeva Reinforces Leadership Position in Respiratory with Acquisition of Gecko Health InnovationsNYSE:TEVATeva Pharmaceutical Industries Ltd
24/09/201518h02Dow Jones NewsGlaxo Asthma Drug Clears Key Hurdle in EuropeNYSE:TEVATeva Pharmaceutical Industries Ltd
21/09/201515h00Dow Jones NewsMylan Moves to Cancel `Stichting` Takeover DefenseNYSE:TEVATeva Pharmaceutical Industries Ltd
 Showing the most relevant articles for your search:NYSE:TEVA

Dernières Valeurs Consultées

NASDAQ
MLACU
Malacca Straits Acquisit...
BIT
FLOT
Exchange Traded
LSE
SOI
Schroder Oriental Income
USOTC
BAMGF
Brookfield (PK)
TSX
BLDP
Ballard Power Systems
NASDAQ
LMNX
Luminex
NYSE
VMO
Invesco Municipal Opport...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés